INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) - USD ($)	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021
Change in unrealized gain in investment	$ (1,809,000)	$ (3,069,000)
Imagion Biosystems, Inc. [Member]
Change in unrealized gain in investment	$ (1,809,000)
Common stock owned shares	51,766,508
Trading price per share	$ 0.03
Fair value of investment	$ 1,064,000

Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 5D
-Subparagraph (SX 210.12-13D(Column C))
-URI https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-URI https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010

Name:	us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant